Clinical trial
Preoperative Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases (Stage IIIA, N2)
NCT00003231 is registered in ClinicalTrials.gov with Swiss Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Preoperative Chemotherapy in Non-Small Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases (Stage IIIA, N2)
- Lead sponsor
- Swiss Cancer Institute
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 1997
- Completion date
- September 30, 2000
- Enrollment
- 40 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer